Sopharma : Consolidated financial results for the first half of 2021
August 30, 2021 at 10:12 am EDT
Share
Sopharma Group
Consolidated financial results for the first half of 2021
Consolidated financial results for the first half of 2021
Who are we?
Sopharma Group
The Group is a leading, vertically-integrated Bulgarian manufacturer, exporter and distributor of
pharmaceutical and other health related products with a strong presence in Southern and Eastern Europe, offering a wide range of prescription and OTC pharmaceutical products and other health related products and services.
The Group works in the following areas:
Production of active pharmaceutical ingredients;
• Pharmaceutical production;
Wholesale and distribution;
• Non-pharmaceutical activities.
"Sopharma" AD
Bulgarian based mother company,
pharmaceutical producer
API production
Farmer, Bulgaria
Farming of
medicinal plants
"Sopharma" AD ,
Kazanlak Bulgaria
Extraction of active
ingredients
Pharmaceuticals
production
"Sopharma" AD , Bulgaria Self-developedproducts from herbal origin, Generic products
"Biopharm Engineering"
AD, Bulgaria and PAO
"Vitamini" Ukraine
Generic products
Veterinary products
Wholesale and
distribution
"Sopharma Trading" AD,
Bulgaria and Serbia
Pre-wholesaling, wholesaling, retail
"BRIZ" Latvia and
Sopharma 100% owned subsidiaries in Ukraine, Kazakhstan, Poland and etc.
Wholesaling, retail
Non-pharma activities
"Biopharm Engineering"
AD
Veterinary products, sterile
production
"Momina Krepost" AD
Plastic disposable materials
Brief history and key milestones:
Local pharmaceutical community starts construction of the first laboratory for production of medicinal products
• Privatization -
•
Licensed its production
facilities according to the
"Sopharma" AD
European GMP
becoming a
•
Increased production capacity
• Listing on Warsaw
privately held
through acquisition of
pharmaceutical
•
New modern
"Bulgarian Rose Sevtopolis" AD
Stock Exchange
company
pharmaceutical
plant Vrabevo
• Acquired a very
opened for
active distributor
production of
"Briz" OOD in
medicinal
Latvia
products
• Transformation
through merger
• First generic
between "Medica" AD
in urology -
and "Sopharma" AD
Urimax Duo
Transformation
through merger
•
"Sopharma"AD
between
sold the shares
"Unipharm" AD and
owned by it
"Sopharma" AD
• Focus on
from the capital
of "Aromania"
R&D
AD
1933
1953
1999
2000
2002
2003
2004
2005
2006
2009
2011
2013
2014
2017
2018
2019
2020
"Sopharma" AD nationalized
Start of production:
1956 - Nivalin
• 1964 - Tabex
1981 - Tribestan
"Sopharma" AD listed on BSE.
Acquired five small
• Construction of new production
"Sopharma Trading" AD
producers:
•
Opened the state-of-
facilities in Sofia and Serbia
acquires sole control
•
"Unipharm" AD
the-art logistics
• First successful registration of
•
"Vramed" AD
terminal for
over the companies
Sopharma's product in old EU
•
"Pharmachim Holding" AD
distribution of
"SCS Franchise" AD and
(Nivalin in Austria)
•
"NIHFI" AD
pharmaceutical
"Sanita Franchising" AD
• Control stake acquisition in
•
"Rostbalkanpharm"
products (European
"Unifarm" AD
GDP certified)
•
"Sopharma"
• Penetrating into distribution
AD celebrates
its 85th
business by acquiring "Sopharma
anniversary
Trading" AD
Modern history - period of constant modernization and development
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Sopharma AD published this content on 30 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 August 2021 14:11:01 UTC.
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.